Added-value innovations drive Covidien’s neurovascular pipeline
This article was originally published in Clinica
A steady flow of innovation has earned Covidien’s neurovascular unit the position as one of the group’s star performers. Tina Tan finds out from the business’s president Brett Wall what else is in the pipeline
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.